Armenia vs Sur: Previously treated cases tested for RR-/MDR-TB
Armenia
100.0%
in 2024
Sur
62.0%
in 2024
Armenia rank
1st
Sur rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Armenia
- Sur
How they compare
Armenia currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Armenia's figure about 1.6 times Sur's.
The two have swapped places 6 times across 17 shared years of data; in 2005 it was Armenia ahead.
Armenia ranks 1st and Sur ranks 1st of 180 countries.
Across the 3 decades both report, Armenia averaged higher in 2 and Sur in 1.
Head to head by decade
| Decade | Armenia | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.3% | 14.3% | 27.0% | Armenia |
| 2010s | 41.7% | 53.0% | 11.3% | Sur |
| 2020s | 98.4% | 78.4% | 20.0% | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Armenia or Sur?
- Armenia, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Armenia and Sur?
- 38.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Sur?
- 17 years are reported by both, from 2005 to 2024.
- How do Armenia and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Armenia ranks 1st and Sur ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.